🇬🇧 United Kingdom Country × Condition
neoplasms by histologic type Clinical Trials in United Kingdom
Active clinical trials for neoplasms by histologic type with research sites in United Kingdom. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2, Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇬🇧 United Kingdom
Active Trials in United Kingdom (2)
NCT05770544 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
Enrollment
30 pts
Country
🇬🇧 United Kingdom
Cancer Research UK
View Trial → NCT06988475 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
Enrollment
30 pts
Country
🇬🇧 United Kingdom
Cancer Research UK
View Trial → Frequently Asked Questions
How many neoplasms by histologic type clinical trials are active in United Kingdom?
There are currently 2 active clinical trials for neoplasms by histologic type with sites in United Kingdom, of which 2 are actively recruiting patients.
How can I join a neoplasms by histologic type clinical trial in United Kingdom?
To join a neoplasms by histologic type clinical trial in United Kingdom, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in United Kingdom directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are neoplasms by histologic type trials in United Kingdom?
Active neoplasms by histologic type trials in United Kingdom span Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.